Clinical Trial Update: Paradoxical Stimulation of Hepatic Glucose Production With Dapagliflozin [Phase 3]

View source ↗

Summary

Phase 3 trial update on dapagliflozin indicating paradoxical stimulation of hepatic glucose production; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Type II; Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2019-12-18